Haptic

feel the technology

MENUMENU
  • Home
    • HAPTIC R&D CONSULTING
    • Our goal is your target in a future visionary way to create a synergy business bridge between SME’s companies and R&D laboratories to merge together in revolutionary and innovation projects.

    • Recent Posts

      • Not all investments for rural development deliver durable benefits
      • 2022 CRITICAL INFRASTRUCTURE PROTECTION FORUM
      • Closing the EU’s innovation gap: Member States must get more involved
      • EU’s energy taxation policies don’t square with its climate goals
      • Talking about innovation can hurt a firm’s market performance but enhance earnings
  • Technology
    • HAPTIC
    • Industry 4.0
    • Internet of Things
    • WEARABLE
    • Funding Opportunities
      • News Release
    • Reports
  • Events
    • EXPO & CONFERENCES
      • High-Tech
      • ICT
      • Biotechnology
      • Nanoengineering
      • Energy
      • Materials Science
      • Healthcare
    • Upcoming Events

      1. Commercial UAV Expo 2022

        September 6 @ 8:00 AM - September 8 @ 5:00 PM UTC-7
      2. FABEX Saudi Arabia 2022

        October 2 @ 8:00 AM - October 5 @ 5:00 PM +03
      3. FUTURE FORCES Forum & Exhibition

        October 19 @ 8:00 AM - October 21 @ 5:00 PM CEST

      View All Events

    • KEYNOTE SPEAKER

      Increase Your Power Audience
      ’’Spending the Time Researching Your Industry, your Issues, and Your audience’’

  • Market Reports And Products
    • INDUSTRY 4.0

    • ELECTRONICS

    • VR/AR/AI

    • HEALTHCARE

    • MACHINERY EQUIPMENT

    • ENERGY

    • SERVICES INDUSTRY

    • MANUFACTURING CONSTRUCTION

    • Checkout
    • My Account
    • Basket
  • Partners
  • Contact Us

Virtual reality and real-time haptic feedback technology to create a realistic surgical experience

Posted on Saturday November 12th, 2016Saturday November 12th, 2016 by Haptic

Pacira Pharmaceuticals, Inc.(NASDAQ:PCRX) introduced a revolutionary new virtual reality simulation intended to provide clinicians with an immersive, hands-on training experience to reinforce the recommended technique for administering EXPAREL (bupivacaine liposome injectable suspension) in total knee arthroplasty (TKA) based on the infiltration protocol developed as part of the company’s ongoing Phase 4 TKA study. This cutting-edge training tool utilizes virtual reality and real-time haptic feedback technology to create a realistic surgical experience in a risk-free computer-generated environment. It is being unveiled at the 2016 Annual Meeting of the American Association of Hip and Knee Surgeons (AAHKS) in Dallas.

simulatorPacira developed the platform in partnership with a steering committee of orthopedic surgeons currently utilizing EXPAREL for their knee replacement patients’ postsurgical pain management to ensure the specifics of the infiltration process are appropriately captured and the simulation accurately replicates the real-world clinician experience. Beyond being visually immersed in the virtual infiltration procedure, a haptic stylus enables users to experience the sensation of injecting EXPAREL into varying tissue layers and types. Users receive real-time feedback with visual heat maps showing their actual infiltration results compared to the ideal distribution of EXPAREL throughout the surgical site.

“As a clinician who has experienced first-hand the impact of an enhanced recovery protocol in my total knee arthroplasty patients, I have found the addition of EXPAREL as part of a robust periarticular injection to be instrumental in pain relief and in patients’ postsurgical recovery. I was thrilled to be part of the working group who helped refine and perfect this comprehensive commitment to education that Pacira is making,” said steering committee member Stan Dysart, MD, who is a practicing orthopedic surgeon at Wellstar Kennestone and Pinnacle Orthopaedics in Marietta, GA. “In my own practice, I saw increasingly optimized and replicable outcomes with EXPAREL as I fine-tuned my infiltration technique to include an appropriate volume of solution, the proper multimodal protocol, and a precise injection technique. I am pleased to help share that insight with my colleagues and their patients alike.”

To further support clinician education, Pacira is simultaneously launching a new virtual training engine developed in collaboration with the mobile training platform Touch Surgery. The unique gaming experience is the first of its kind within the extensive Touch Surgery library of modules and provides users with the on-demand ability to practice infiltrating EXPAREL in a TKA by manipulating the exposure and angle of the knee, the angle of the syringe, the location of the injections, and the amount of volume distributed throughout the surgical site, all from the convenience of their smartphone or iPad. The Touch Surgery mobile app is available for free-of-charge download on iTunes, and will soon be released for the Android platform.

AAHKS 2016 attendees are invited to experience the virtual reality platform for themselves by visiting the Pacira booth (#907) at any point over the duration of the AAHKS conference.

EXPAREL is indicated for single-dose administration into the surgical site to produce postsurgical analgesia. Pacira expects results from the Phase 4 randomized, controlled TKA trial (PILLAR) early next year.

About Pacira
Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) is a specialty pharmaceutical company focused on the clinical and commercial development of new products that meet the needs of acute care practitioners and their patients. The company’s flagship product, EXPAREL®(bupivacaine liposome injectable suspension), a non-opioid local analgesic for postsurgical pain control, was commercially launched in the United States in April 2012. EXPAREL and two other products have successfully utilized DepoFoam®, a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. Additional information about Pacira is available at www.pacira.com.

About EXPAREL®
EXPAREL (bupivacaine liposome injectable suspension) is currently indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia. The product combines bupivacaine with DepoFoam®, a proven product delivery technology that delivers medication over a desired time period. EXPAREL represents the first and only multivesicular liposome local anesthetic that can be utilized in the peri- or postsurgical setting. By utilizing the DepoFoam platform, a single dose of EXPAREL delivers bupivacaine over time, providing significant reductions in cumulative pain score with up to a 45 percent decrease in opioid consumption; the clinical benefit of the opioid reduction was not demonstrated. Additional information is available at www.EXPAREL.com.

Source: Pacira

Related Posts:

  • Haptics device creates realistic virtual textures
    Haptics device creates realistic virtual textures
  • Towards a green, digital and resilient economy
    Towards a green, digital and resilient economy
  • Wireless devices also use haptic feedback to talk to patient
    Wireless devices also use haptic feedback to talk to patient
  • EU Health: European Health Data Space (EHDS)
    EU Health: European Health Data Space (EHDS)
  • What is the Technical Support Instrument
    What is the Technical Support Instrument
  • EU budget 2023
    EU budget 2023
  • EU and international partners put forward a Declaration for the Future of the Internet
    EU and international partners put forward a Declaration for…
  • Internet of Skills enabling real-time transmission of haptic sensation
    Internet of Skills enabling real-time transmission of haptic…
This entry was posted in Virtual Reality and tagged EXPAREL, haptic, immersive, Pacira Pharmaceuticals, real-time haptic feedback technology, Touch Surgery mobile app. Bookmark the permalink.

Post navigation

← Breakthrough Immersive Stadium Experience With Expway
Heat-resistant, high magnetic properties magnet for motors →

Language:

  • English
  • Română

HAPTIC R&D CONSULTING

FUNDS OPPORTUNITY

Are you looking to finance your project, product or idea?

Contact us for support

BUSINESS

  • Events Media Partner
  • solar energy
    PV Flexible Thin Film
  • CRM software
    AOD Management Software
  • Remote Support Assistant (AR)
  • Airport Security Software
  • LAWYER Software
  • CardioMed Software

COOPERATION & PARTNERSHIPS

Who can have a cooperation and a partnership with us?

SMES’s COMPANIES

R&D LABS

RESEARCHERS

INVENTORS

EVENTS ORGANIZATIONS

Upcoming Events

  1. Commercial UAV Expo 2022

    September 6 @ 8:00 AM - September 8 @ 5:00 PM UTC-7
  2. FABEX Saudi Arabia 2022

    October 2 @ 8:00 AM - October 5 @ 5:00 PM +03
  3. FUTURE FORCES Forum & Exhibition

    October 19 @ 8:00 AM - October 21 @ 5:00 PM CEST
  4. Digital Transformation Conference

    November 1 @ 8:00 AM - November 2 @ 5:00 PM GMT
  5. EGYMEDICA 2023

    18/05/2023 @ 8:00 AM - 20/05/2023 @ 5:00 PM EEST

View All Events

Products And Market Research Reports

HAPTIC BUSINESS

  • Events Media Partner
  • solar energy
    PV Flexible Thin Film
  • CRM software
    AOD Management Software
  • Remote Support Assistant (AR)
  • Airport Security Software
  • LAWYER Software
  • CardioMed Software

Upcoming Events

  1. Commercial UAV Expo 2022

    September 6 @ 8:00 AM - September 8 @ 5:00 PM UTC-7
  2. FABEX Saudi Arabia 2022

    October 2 @ 8:00 AM - October 5 @ 5:00 PM +03

View All Events

Privacy Policy

Cookies

ANPC
info[at]haptic[dot]ro
Work with Us
HAPTIC R&D CONSULTING
+40769238876
  • Facebook link
  • Twitter link
  • Linkedin link
  • Behance link

© Haptic.ro 2016 - 2021

Zerif Lite developed by ThemeIsle